Skip to content
Politically.com Search all
Menu

2026 · 1st Quarter (Jan 1 - Mar 31)

PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)

Filed by DESIMONE CONSULTING, LLC.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
1st Quarter - Report
Posted
Apr 14, 2026
Income
$30,000.00
Expenses
Not reported
Filing UUID
8278802c-62c1-42bf-931c-c36548ae7af6
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

PHA · Pharmacy

Issues related to patient access and pricing. Issues related to policy changes to Medicare Part D. Issues related to 340B reform. Issues related to Most Favored Nation (MFN) policy. Issues related to PBM reform; H.R.4317, PBM Reform Act of 2025; S.3345, PBM Price Transparency and Accountability Act; H.R.7148, Making further consolidated appropriations for the fiscal year ending September 30, 2026, and for other purposes (P.L.119-75).

Literal federal measure citations: H.R.4317, S.3345, H.R.7148

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.